ACE and hydrops fetalis: The employment of the sodium-glucose transporter-2 inhibitor, dapagliflozin in the setting of ACE inhibitors, ARBs, or sacubitril-valsartan plus a beta-blocker has also been shown to reduce all-cause mortality and worsening HF in adults with NYHA Class II-IV with or without diabetes mellitus [35].